International registry: genetic and phenotypic characteristics of a heterogenous group of disorders by Zeidler, Cornelia et al.
POSTER PRESENTATION Open Access
International registry: genetic and phenotypic
characteristics of a heterogenous group of
disorders
Cornelia Zeidler
*, Gusal Pracht, Manuela Germeshausen, Karl Welte
From 5th European Conference on Rare Diseases (ECRD 2010)
Krakow, Poland. 13-15 May 2010
Severe congenital neutropenia (CN) stands for a group
of disorders characterised by extremely low neutrophil
counts (ANC < 0.5x109), early stage maturation arrest
of myelopoiesis and recurrent bacterial infections. In
general more than 90% of CN patients respond to daily
G-CSF treatment with a sustained neutrophil increase
resulting in significantly reduced infections and an
improved quality of life. Besides neutropaenia, the differ-
ences in treatment response and the presence of various
concomitant clinical features in subpopulations of
patients in conjunction with an increased risk of leukae-
mia transformation in about 10% of all CN patients
strongly suggested to search for new sub diagnoses to
identify patients at risk of leukaemia.
Within Europe the SCNIR has collected longitudinal
clinical data on more than 493 patients with various
causes of CN (289 congenital, 64 cyclic, 132 idiopathic
and 8 others) from 22 countries. This unique resource
of data was used to identify new genes, classify patients
by genetic subtypes of CN, estimate their relative fre-
quency and correlate genetic subtypes with prognosis
and outcome.
To date, more than 10 disease causing gene mutations
have be identified in congenital neutropaenia patients.
In approximately 50-60% of all patients autosomal
dominant mutations in the ELANE gene are present.
Initial genotype-phenotype correlation identified a group
of different genetic defects sharing a high risk of leukae-
mia transformation in contrast to others with no
increased risk of leukaemia.
The identification of new CN subtypes, their distinc-
tive risk of malignant transformation and the response
to treatment has contributed substantially to our general
understanding of neutropaenia. New risk adapted strate-
gies for diagnosis and treatment have to be implemented
in the management of CN patients.
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